J1813Drugs Administered Other than Oral Method
Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50
Short description: Lyumjev for insulin pump use
- Effective date
- January 1, 2024
- Termination date
- —
Related codes (J-series)
J0013Esketamine, nasal sprayJ0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injectionJ0121Inj., omadacycline, 1 mgJ0122Inj., eravacycline, 1 mgJ0129Abatacept injectionJ0130Abciximab injectionJ0131Inj, acetaminophen (nos)J0132Acetylcysteine injectionJ0133Acyclovir injectionJ0134Inj acetaminophen -freseniusJ0135Adalimumab injection
Frequently asked questions
What is HCPCS code J1813?
J1813 is a HCPCS Level II code for Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50.
What category is HCPCS code J1813 in?
J1813 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.
When did HCPCS code J1813 become effective?
J1813 has been effective since January 1, 2024, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.